Back to Results

Vitro SAB de CV ADR (VITOF)

Vitro SAB de CV ADR is a depositary receipt listed on OTC Markets that represents shares of Vitro, S.A.B. de C.V. The underlying issuer, through its subsidiaries, produces, processes, distributes, and sells inorganic chemical products across global markets. Its product range includes sodium carbonate and bicarbonate, calcium chloride, and sodium chloride, which are used in applications spanning automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors. Vitro was founded in 1909 and is headquartered in San Pedro Garza García, Mexico.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-VITO.F
$0.17
-83.5% Downside
Expensive
—
—
—
Good
—
—
—
0.0%
July 24, 2026
1.0x
0.2x
0.5x
135.2 M
135.5 M
2.3%
8.8%
7.6
—
79.9%
Valuation • Fair Value

Vitro SAB de CV ADR (OTC-VITO.F) Fair Value by Valuation Model

Compare the primary fair value estimate for Vitro SAB de CV ADR (OTC-VITO.F) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.17

Estimated downside of 83.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.13

Discounted cash flow valuation reference.

Ben Graham Formula Value

$1.44

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$0.25

Earnings power value estimate.

Comps Fair Value

$0.15

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Vitro SAB de CV ADR (OTC-VITO.F) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Vitro SAB de CV ADR (OTC-VITO.F)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

284.4 M

Current operating scale indicator.

Revenue Forecast

282 M

Forward revenue estimate.

EBITDA

9.15 M

Current operating profitability reference.

EBITDA Forecast

500 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Vitro SAB de CV ADR (OTC-VITO.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Vitro SAB de CV ADR (OTC-VITO.F)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-1.88

Intermediate zone that deserves monitoring.

Altman Z-Score

7.6

Relatively strong balance-sheet zone.

FCF / Net Income

79.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Vitro SAB de CV ADR (OTC-VITO.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Vitro SAB de CV ADR (OTC-VITO.F)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 24, 2026

Days to Earnings

3

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Vitro SAB de CV ADR (OTC-VITO.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Vitro SAB de CV ADR (OTC-VITO.F) Stock Forecast & Technical Outlook

Review Vitro SAB de CV ADR (OTC-VITO.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Not available

The 15-minute technical signal for Vitro SAB de CV ADR (OTC-VITO.F) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Not available

The 1-hour technical signal for Vitro SAB de CV ADR (OTC-VITO.F) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Vitro SAB de CV ADR (OTC-VITO.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Vitro SAB de CV ADR (OTC-VITO.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Vitro SAB de CV ADR (OTC-VITO.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Vitro SAB de CV ADR (OTC-VITO.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Vitro SAB de CV ADR (OTC-VITO.F) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Vitro SAB de CV ADR (OTC-VITO.F) Stock FAQ

Quick answers about Vitro SAB de CV ADR (OTC-VITO.F) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.17
Estimated downside 83.5%
Valuation Rating
Overvalued
Estimated downside of 83.5%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Good
Current financial-health read

The current fair value estimate for Vitro SAB de CV ADR (OTC-VITO.F) is $0.17. This implies an estimated downside of 83.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 83.5% versus the current market price.

An analyst price target for Vitro SAB de CV ADR (OTC-VITO.F) is not currently available in the latest data file.

The current financial health read for Vitro SAB de CV ADR (OTC-VITO.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Vitro SAB de CV ADR (OTC-VITO.F) is July 24, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Vitro SAB de CV ADR (OTC-VITO.F) is 1.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Vitro SAB de CV ADR is 135.2 M.

The current enterprise value listed for Vitro SAB de CV ADR is 135.5 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Vitro SAB de CV ADR is OTC-VITO.F, and the stock is listed on OTC Markets.

Vitro SAB de CV ADR (OTC-VITO.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Vitro SAB de CV ADR is 2.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Vitro SAB de CV ADR is 8.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Containers & Packaging Stocks on OTC Markets View more

Klabin Sa A (KLBAY) Klabin Sa A (KLBAY)
Orora Ltd ADR (ORRYY) Orora Ltd ADR (ORRYY)
Viskase Holdings, Inc. (ENZN) Viskase Holdings, Inc. (ENZN)
Chase Packaging Corp (WHLT) Chase Packaging Corp (WHLT)
Vapor Group Inc (VPOR) Vapor Group Inc (VPOR)
Advanced Container Technologies Inc (ACTX) Advanced Container Technologies Inc (ACTX)